FDA’s institutional review board committee
Executive Summary
FDA Assistant Commissioner for Science Linda Tollefson becomes the new chair of FDA's Institutional Review Board's Research Involving Human Subjects Committee July 1. She replaces former RIHSC chair and FDA's Office of Orphan Products Development Deputy Director John McCormick, who plans to retire from the agency soon. McCormick was RIHSC chairman for three and a half years and served as deputy director of OOPD for eight years of his 16 years with the office. His successor at OOPD has not yet been determined, FDA says...
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.